Synergistic effects of antibodies against high-mobility group box 1 and tumor necrosis factor-α antibodies on d-(+)-galactosamine hydrochloride/lipopolysaccharide-induced acute liver failure

Authors

  • Wei Wang,

    1. Center for Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
    2. University of Chinese Academy of Sciences, Beijing, China
    Search for more papers by this author
  • Li Sun,

    1. Center for Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
    2. University of Chinese Academy of Sciences, Beijing, China
    Search for more papers by this author
  • Yonghao Deng,

    1. Center for Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
    2. University of Chinese Academy of Sciences, Beijing, China
    Search for more papers by this author
  • Jie Tang

    Corresponding author
    • Center for Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
    Search for more papers by this author

Correspondence

J. Tang, Center for Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Room 1407, 15 Datun Road, Chaoyang District, Beijing 100101, China

Fax: +86 10 64840932

Tel: +86 10 64888447

E-mail: jtang@sun5.ibp.ac.cn

Abstract

High-mobility group box 1 (HMGB1) protein is released into the serum after tissue damage, and serves as a warning signal to enhance the inflammatory response. Acute liver injury is one of the diseases that starts with tissue damage and ends with systemic inflammation. We used d-(+)-galactosamine hydrochloride (d-GalN)/lipopolysaccharide (LPS)-treated mice as an acute liver injury model to explore the functions of HMGB1 in more detail. HMGB1 is released into the serum at a very early stage of d-GalN/LPS-induced acute liver injury. It upregulates the expression of tumor necrosis factor-α (TNF-α), interleukin-6, inducible nitric oxide synthase, and tissue factor. TNF-α and HMGB1 form a positive feedback loop to amplify the downstream signals. mAbs against HMGB1 and TNF-α have synergistic effects in protecting mice from d-GalN/LPS-induced acute liver failure. The results suggest that HMGB1 is a key mediator in d-GalN/LPS-induced acute liver injury. Tissue damage and cell necrosis shortly after administration of d-GalN and LPS lead to early HMGB1 release, and HMGB1 acts synergistically with TNF-α to promote pathological processes in acute liver failure.

Ancillary